STOCK TITAN
  1. Home
  2. Sec-filings
  3. WGRX
  4. [8-K/A] Wellgistics Health, Inc. Amends Material Event Report

Wellgistics (NASDAQ: WGRX) clarifies Amended Settlement Agreement

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K/A

Rhea-AI Filing Summary

Wellgistics Health, Inc. filed an amended current report to correct the cover-page report date to February 9, 2026 and to restate its description of a key contract. The company explains that the material definitive agreement for disclosure purposes is an Amended Settlement Agreement entered on February 9, 2026 with Silverback Capital Corporation, which modifies an earlier settlement agreement referenced in the original report. All other disclosures from the original report remain unchanged.

Positive

  • None.

Negative

  • None.
Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Amended Settlement Agreement financial
"entered into an Amended Settlement Agreement (the “Amended Settlement Agreement”) with Silverback Capital Corporation"
Material Definitive Agreement regulatory
"constitutes the material definitive agreement for purposes of Item 1.01"
A material definitive agreement is a legally binding contract that creates major, long‑term obligations or rights for a company, such as loans, asset sales, mergers, or supplier deals. Think of it like a mortgage or lease for a business: it can change future cash flow, risk and control, so investors watch these agreements closely because they can materially affect a company’s value, financial health and stock price.
Emerging growth company regulatory
"Emerging growth company Explanatory Note"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
Understanding 8-K Material Events →
true 0002030763 0002030763 2026-02-09 2026-02-09 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K/A

Amendment No. 1

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): February 9, 2026

 

WELLGISTICS HEALTH, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-42530   93-3264234

(State or other jurisdiction

of incorporation)

  

(Commission

File Number)

  

(IRS Employer

Identification No.)

 

3000 Bayport Drive

Suite 950

Tampa, FL 33607

(Address of principal executive offices, including zip code)

 

Registrant’s telephone number, including area code: (844) 203-6092

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

  ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
  ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
  ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
  ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
         
Common Stock, $0.0001 par value per share   WGRX   The Nasdaq Capital Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 
 

 

Explanatory Note

 

This Amendment No. 1 to Current Report on Form 8-K (this “Amendment”) amends the Current Report on Form 8-K filed by Wellgistics Health, Inc. (the “Company”) on February 13, 2026 (the “Original Report”). The purpose of this Amendment is to correct the Date of Report on the cover page of the Original Filing to February 9, 2026, and to restate Item 1.01 in its entirety.

 

 
 

 

Item 1.01. Entry into a Material Definitive Agreement.

 

The disclosure set forth in Item 1.01 of the Original Report is hereby amended and restated in its entirety as follows:

 

On February 9, 2026, Wellgistics Health, Inc. (the “Company”) entered into an Amended Settlement Agreement (the “Amended Settlement Agreement”) with Silverback Capital Corporation, which amended that certain Settlement Agreement previously referenced in the Original Report (the “Original Settlement Agreement”).

 

The Company is filing this Amendment No. 1 to clarify that the entry into the Amended Settlement Agreement on February 9, 2026 constitutes the material definitive agreement for purposes of Item 1.01 of Form 8-K.

 

Except as expressly set forth herein, the disclosures contained in the Original Report remain unchanged.

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: May 4, 2026 WELLGISTICS HEALTH, INC.
     
  By: /s/ Prashant Patel
    Prashant Patel, President

 

 

 

Source: View Original Filing on SEC EDGAR

FAQ

What does Wellgistics Health (WGRX) change in this 8-K/A filing?

Wellgistics Health changes the reported event date to February 9, 2026 and fully restates Item 1.01. The amendment clarifies that a new Amended Settlement Agreement entered on that date is the material definitive agreement being disclosed.

Which agreement is now treated as the material definitive agreement for Wellgistics Health (WGRX)?

The material definitive agreement is the Amended Settlement Agreement dated February 9, 2026 with Silverback Capital Corporation. It replaces the previously referenced original settlement agreement for purposes of the company’s Item 1.01 disclosure.

Who is Wellgistics Health (WGRX) counterpart in the Amended Settlement Agreement?

Wellgistics Health’s counterparty is Silverback Capital Corporation. The company states it entered into an Amended Settlement Agreement with Silverback on February 9, 2026, and this revised contract is the agreement disclosed as material under Item 1.01.

Does the Wellgistics Health (WGRX) amendment change other parts of the original report?

The amendment limits changes to the report date and Item 1.01 description. Wellgistics Health specifies that, except for these clarifications surrounding the Amended Settlement Agreement, all other disclosures from the original current report remain unchanged.

Why did Wellgistics Health (WGRX) file Amendment No. 1 to its current report?

Wellgistics Health filed Amendment No. 1 to correct the Date of Report on the cover page to February 9, 2026 and to clarify that the Amended Settlement Agreement with Silverback Capital Corporation is the material definitive agreement for Item 1.01 disclosure.

Filing Exhibits & Attachments

3 documents

Other Documents